Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Novel Cholinergic Biomarkers in Dementia: An Imaging Study Using Brain Quantitative Structural Magnetic Resonance Imaging and Eye Optical Coherence Tomography
FY 2020-21
Summary
Dementia is one of ten leading causes of death in Canada. Dementia is a syndrome that leads to loss of cognitive function and independence. Delaying its onset by just 2 years can decrease its incidence by 19% and its economic burden by $218 billion in the next 30 years in Canada. While there is no cure for dementia, investigational interventions appear most effective in early stages of the disease. As such, detecting dementia's underlying disease process early is important. A major contributor to loss in cognitive function in the commonest diseases leading to dementia is degeneration of the brain's cholinergic system, which regulates attention and memory. I intend to make early detection of this system's degeneration quicker and less expensive by proposing a novel eye biomarker.
To test this eye biomarker, I will investigate whether the volume of certain cholinergic-rich layers of an eye structure called the retina correlate with the volume of the brain's cholinergic-rich center and certain indicators of cognition in individuals with common diseases leading to dementia, such as Alzheimer's and Parkinson's disease. These individuals will mostly be in the early stages of the disease. Both the brain's and retina's cholinergic rich-centers have been shown to undergo changes in their volume in dementia, but their correlation has not been investigated to date. For this investigation I will consider factors that may impact my analysis, for example the type of dementia the individual has, as well as their age and sex. Should eye biomarkers correlate with brain biomarkers, this can be a potential screening tool that is both more time and cost effective than brain imaging or neuropsychiatric tests for the detection of dementia in the early disease stage when investigational interventions appear to be most effective. I hope my work in early detection of dementia will help advance the cause of Canada's national strategy to better understand dementia and decrease its burden.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
439364
Name
Banihashemi M. Amin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Novel Cholinergic Biomarkers in Dementia: An Imaging Study Using Brain Quantitative Structural Magnetic Resonance Imaging and Eye Optical Coherence Tomography
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Biomarkers; Cholinergic System; Dementia; Magnetic Resonance Imaging; Neurodegenerative Diseases; Nucleus Basalis Of Meynert; Optical Coherence Tomography; Parkinson'S Disease; Retina
Abstract
Dementia is one of ten leading causes of death in Canada. Dementia is a syndrome that leads to loss of cognitive function and independence. Delaying its onset by just 2 years can decrease its incidence by 19% and its economic burden by $218 billion in the next 30 years in Canada. While there is no cure for dementia, investigational interventions appear most effective in early stages of the disease. As such, detecting dementia's underlying disease process early is important. A major contributor to loss in cognitive function in the commonest diseases leading to dementia is degeneration of the brain's cholinergic system, which regulates attention and memory. I intend to make early detection of this system's degeneration quicker and less expensive by proposing a novel eye biomarker.
To test this eye biomarker, I will investigate whether the volume of certain cholinergic-rich layers of an eye structure called the retina correlate with the volume of the brain's cholinergic-rich center and certain indicators of cognition in individuals with common diseases leading to dementia, such as Alzheimer's and Parkinson's disease. These individuals will mostly be in the early stages of the disease. Both the brain's and retina's cholinergic rich-centers have been shown to undergo changes in their volume in dementia, but their correlation has not been investigated to date. For this investigation I will consider factors that may impact my analysis, for example the type of dementia the individual has, as well as their age and sex. Should eye biomarkers correlate with brain biomarkers, this can be a potential screening tool that is both more time and cost effective than brain imaging or neuropsychiatric tests for the detection of dementia in the early disease stage when investigational interventions appear to be most effective. I hope my work in early detection of dementia will help advance the cause of Canada's national strategy to better understand dementia and decrease its burden.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Banihashemi, M. Amin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~